258 related articles for article (PubMed ID: 27384677)
1. Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells.
Avino S; De Marco P; Cirillo F; Santolla MF; De Francesco EM; Perri MG; Rigiracciolo D; Dolce V; Belfiore A; Maggiolini M; Lappano R; Vivacqua A
Oncotarget; 2016 Aug; 7(33):52710-52728. PubMed ID: 27384677
[TBL] [Abstract][Full Text] [Related]
2. Discoidin domain receptor 1 modulates insulin receptor signaling and biological responses in breast cancer cells.
Vella V; Malaguarnera R; Nicolosi ML; Palladino C; Spoleti C; Massimino M; Vigneri P; Purrello M; Ragusa M; Morrione A; Belfiore A
Oncotarget; 2017 Jun; 8(26):43248-43270. PubMed ID: 28591735
[TBL] [Abstract][Full Text] [Related]
3. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway.
Matà R; Palladino C; Nicolosi ML; Lo Presti AR; Malaguarnera R; Ragusa M; Sciortino D; Morrione A; Maggiolini M; Vella V; Belfiore A
Oncotarget; 2016 Feb; 7(7):7683-700. PubMed ID: 26655502
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I regulates GPER expression and function in cancer cells.
De Marco P; Bartella V; Vivacqua A; Lappano R; Santolla MF; Morcavallo A; Pezzi V; Belfiore A; Maggiolini M
Oncogene; 2013 Feb; 32(6):678-88. PubMed ID: 22430216
[TBL] [Abstract][Full Text] [Related]
5. GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts.
Pisano A; Santolla MF; De Francesco EM; De Marco P; Rigiracciolo DC; Perri MG; Vivacqua A; Abonante S; Cappello AR; Dolce V; Belfiore A; Maggiolini M; Lappano R
Mol Carcinog; 2017 Feb; 56(2):580-593. PubMed ID: 27341075
[TBL] [Abstract][Full Text] [Related]
6. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer.
Belfiore A; Malaguarnera R; Nicolosi ML; Lappano R; Ragusa M; Morrione A; Vella V
Cell Adh Migr; 2018; 12(4):305-314. PubMed ID: 29486622
[TBL] [Abstract][Full Text] [Related]
7. Novel cross talk between IGF-IR and DDR1 regulates IGF-IR trafficking, signaling and biological responses.
Malaguarnera R; Nicolosi ML; Sacco A; Morcavallo A; Vella V; Voci C; Spatuzza M; Xu SQ; Iozzo RV; Vigneri R; Morrione A; Belfiore A
Oncotarget; 2015 Jun; 6(18):16084-105. PubMed ID: 25840417
[TBL] [Abstract][Full Text] [Related]
8. DDR1 regulates thyroid cancer cell differentiation via IGF-2/IR-A autocrine signaling loop.
Vella V; Nicolosi ML; Cantafio P; Massimino M; Lappano R; Vigneri P; Ciuni R; Gangemi P; Morrione A; Malaguarnera R; Belfiore A
Endocr Relat Cancer; 2019 Jan; 26(1):197-214. PubMed ID: 30121624
[TBL] [Abstract][Full Text] [Related]
9. GPER activates Notch signaling in breast cancer cells and cancer-associated fibroblasts (CAFs).
Pupo M; Pisano A; Abonante S; Maggiolini M; Musti AM
Int J Biochem Cell Biol; 2014 Jan; 46():56-67. PubMed ID: 24275097
[TBL] [Abstract][Full Text] [Related]
10. GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells.
Rigiracciolo DC; Scarpelli A; Lappano R; Pisano A; Santolla MF; Avino S; De Marco P; Bussolati B; Maggiolini M; De Francesco EM
Oncotarget; 2016 Jan; 7(1):94-111. PubMed ID: 26646587
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory effect of IGF-1 is mediated by IGF-1R cross talk with GPER in MPTP/MPP
Yuan LJ; Zhang M; Chen S; Chen WF
Mol Cell Endocrinol; 2021 Jan; 519():111053. PubMed ID: 33035625
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between GPER and growth factor signaling.
Lappano R; De Marco P; De Francesco EM; Chimento A; Pezzi V; Maggiolini M
J Steroid Biochem Mol Biol; 2013 Sep; 137():50-6. PubMed ID: 23542661
[TBL] [Abstract][Full Text] [Related]
13. Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
Rigiracciolo DC; Santolla MF; Lappano R; Vivacqua A; Cirillo F; Galli GR; Talia M; Muglia L; Pellegrino M; Nohata N; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Feb; 38(1):58. PubMed ID: 30728047
[TBL] [Abstract][Full Text] [Related]
14. DDR1 Affects Metabolic Reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System.
Vella V; Giuliano M; Nicolosi ML; Majorana MG; Marć MA; Muoio MG; Morrione A; Maggiolini M; Lappano R; De Francesco EM; Belfiore A
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34206590
[TBL] [Abstract][Full Text] [Related]
15. GPER mediates the angiocrine actions induced by IGF1 through the HIF-1α/VEGF pathway in the breast tumor microenvironment.
De Francesco EM; Sims AH; Maggiolini M; Sotgia F; Lisanti MP; Clarke RB
Breast Cancer Res; 2017 Dec; 19(1):129. PubMed ID: 29212519
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives.
Vella V; Malaguarnera R
Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30513575
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer.
Santolla MF; Avino S; Pellegrino M; De Francesco EM; De Marco P; Lappano R; Vivacqua A; Cirillo F; Rigiracciolo DC; Scarpelli A; Abonante S; Maggiolini M
Cell Death Dis; 2015 Jul; 6(7):e1834. PubMed ID: 26225773
[TBL] [Abstract][Full Text] [Related]
18. G protein-coupled oestrogen receptor promotes cell growth of non-small cell lung cancer cells via YAP1/QKI/circNOTCH1/m6A methylated NOTCH1 signalling.
Shen Y; Li C; Zhou L; Huang JA
J Cell Mol Med; 2021 Jan; 25(1):284-296. PubMed ID: 33237585
[TBL] [Abstract][Full Text] [Related]
19. New advances on the functional cross-talk between insulin-like growth factor-I and estrogen signaling in cancer.
Bartella V; De Marco P; Malaguarnera R; Belfiore A; Maggiolini M
Cell Signal; 2012 Aug; 24(8):1515-21. PubMed ID: 22481093
[TBL] [Abstract][Full Text] [Related]
20. GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells.
Vivacqua A; Romeo E; De Marco P; De Francesco EM; Abonante S; Maggiolini M
Breast Cancer Res Treat; 2012 Jun; 133(3):1025-35. PubMed ID: 22147081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
